Antibodies, Proteins, Kits and Reagents for Life Science

FFN511, Fluorescent substrate for VMAT2 (ab120331)

Description:

First novel fluorescent false neurotransmitter. Enables optical imaging of presynaptic terminal activity.

Application:

Reactivity:

Conjugate:

Terguride, Partial D2 agonist (ab144611)

Description:

Partial D2 agonist. Potent, non-competitive and non-selective 5-HT2 antagonist.

Application:

Reactivity:

Conjugate:

(R)-(+)-SKF38393 hydrochloride, D₁ partial agonist (ab120619)

Description:

Selective D1 partial agonist. Active enantiomer of (±)-SKF-38393.

Application:

Reactivity:

Conjugate:

(R)-Tomoxetine hydrochloride, norepinephrine reuptake inhibitor (ab120758)

Description:

Potent, selective norepinephrine reuptake inhibitor

Application:

Reactivity:

Conjugate:

(R,S)-Sulpiride, D₂-like dopamine receptor antagonist (ab120578)

Description:

D2-like dopamine receptor antagonist

Application:

Reactivity:

Conjugate:

3-Iodo-L-tyrosine (MIT), Tyrosine hydroxylase inhibitor (ab144773)

Description:

Tyrosine hydroxylase inhibitor

Application:

Reactivity:

Conjugate:

Alternariol-9-methyl ether, apoptotic agent (ab143356)

Description:

Mycotoxin. Apoptotic agent.

Application:

Reactivity:

Conjugate:

Amisulpride, D₂/D₃ receptor antagonist (ab142480)

Description:

Potent, highly selective D2/D3 receptor antagonist

Application:

Reactivity:

Conjugate:

Azaperone, anaesthetic adjuvant (ab142486)

Description:

Sedative and anaesthetic adjuvant

Application:

Reactivity:

Conjugate:

Bupropion hydrochloride, Non-selective DAT/NET inhibitor (ab120534)

Description:

Non-selective DAT/NET inhibitor

Application:

Reactivity:

Conjugate:

Dopamine